Prime Minister Carney concludes fall Cabinet Planning Forum focused on building Canada’s economic strength

This week, the Prime Minister, Mark Carney, convened Canada's Cabinet ministers and secretaries of State in Toronto for the fall Cabinet Planning Forum, where they focused on keymissionsand priorities for the next six months. The Forum took place at a critical moment, as the U.S. fundamentally transforms its trade relationships – displacing workers, disrupting industries, […]

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Urged to Join Class Action Before September 15, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=165415&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Bogotá, global hub for sustainability with the 2025 International Summit on Environmental Innovation

— The Summit will bring together representatives from more than 40 countries, over 200 international experts, and 30,000 attendees, consolidating Bogotá as Latin America's leading hub for sustainability and climate action. — The Bogotá Chamber of Commerce is leading efforts to integrate sustainability into business strategies, promoting innovation, partnerships, and more competitive and inclusive business

Smithfield Foods Announces Pricing of Upsized Secondary Offering of Common Stock

(NASDAQ:SFD), SMITHFIELD, Va., Sept. 04, 2025 (GLOBE NEWSWIRE) — Smithfield Foods, Inc. (Nasdaq: SFD) (the “Company”), an American food company and an industry leader in value-added packaged meats and fresh pork, today announced the pricing of a secondary public offering of 19,531,698 shares of common stock of the Company sold by SFDS UK Holdings Limited,

Smithfield Foods Announces Pricing of Upsized Secondary Offering of Common Stock

Smithfield Foods Announces Pricing of Upsized Secondary Offering of Common Stock GlobeNewswire September 05, 2025 SMITHFIELD, Va., Sept. 04, 2025 (GLOBE NEWSWIRE) — Smithfield Foods, Inc. (Nasdaq: SFD) (the “Company”), an American food company and an industry leader in value-added packaged meats and fresh pork, today announced the pricing of a secondary public offering of

Michael Kodari Expands KOSEC – Kodari Securities to the Middle East with New Offices in Downtown Dubai

SYDNEY, AU / ACCESS Newswire / September 4, 2025 / Michael Kodari, Founder and Chief Executive Officer of KOSEC – Kodari Securities, has announced the official opening of KOSEC’s new Middle East headquarters in Boulevard Plaza Tower 2, Sheikh Mohammed bin Rashid Boulevard, Downtown Dubai. This milestone marks KOSEC’s latest international expansion as the firm

Outstanding US Law-Governed USD Instruments Reset Rate Transitioned to Term SOFR

Farmers Insurance Exchange (the “Farmers Exchange”) today announced the following: https://mma.prnewswire.com/media/359564/farmers_insurance_logo_Logo.jpg In October, 2017, Farmers Exchange issued $400 million aggregate principal amount of 4.747% Surplus Notes due November 1, 2057 (the “2057 Notes”), pursuant to the Fiscal Agency Agreement, dated October 16, 2017 (“Fiscal Agency Agreement”), between Farmers Exchange and The Bank of New York

/C O R R E C T I O N — Allies of Skin/

In the news release, Allies of Skin Introduces Advanced Hydration Serum – Hydration, Reinvented, issued 03-Sep-2025 by Allies of Skin over PR Newswire, we are advised by the company of an update to the release. The complete, corrected release follows: Allies of Skin Introduces Advanced Hydration Serum – Hydration, Reinvented The first-of-its-kind Beta Glucan &

MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy

SAN JOSE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) — In August 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy for Posttraumatic Stress Disorder (PTSD). Today, the FDA made this CRL publicly available for the first time, providing transparency into the agency's

MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy

MAPS Statement on FDA's Public Release of Complete Response Letter for MDMA-assisted Therapy GlobeNewswire September 05, 2025 SAN JOSE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) — In August 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy for Posttraumatic Stress Disorder (PTSD).

Scroll to Top